Literature DB >> 31102754

Sirt1 improves functional recovery by regulating autophagy of astrocyte and neuron after brain injury.

Zhuo Zhang1, Dan Li1, Li Xu2, Hong-Peng Li3.   

Abstract

Traumatic brain injury (TBI) triggers neuronal death mechanisms that significantly induce neuronal loss and neurological dysfunction. Our previous study revealed that Sirt1 could improve the neuroprotective effect by reducing the astrocyte activation after TBI. Nevertheless, the underlying mechanisms of Sirt1 attenuating astrocyte activation still remain unclear. The following study examined whether the protection of Sirt1 in nigrostriatal pathway injury is associated with autophagy regulation. We established a nigrostriatal pathway injury in the mouse brain in order to mimic the traumatic brain injury and up-regulated Sirt1 expression by resveratrol. Consequently, we analyzed the effect of Sirt1 up-regulation on LC3 and monitored the LC3 localization in the astrocytes, microglial cells and neurons. We found that the Sirt1 up-regulation by resveratrol increased the expression of LC3 around the lesion site after injury. Confocal results showed that Sirt1 up-regulation increased the expression of LC3 in astrocytes and decreased the expression in the neurons, while low effect was found on the microglial cells. Moreover, compared the resveratrol treatment groups, a typical nucleocytoplasmic localization with strong distribution in the nucleus (in astrocyte and neurons) was observed in the control group (treated with DMSO). To sum up, our data suggested that regulation of Sirt1 expression could enhance autophagy in the astrocytes and decrease the expression in the neurons. This mechanism, which may probably relate to the distribution of LC3 in cytoplasm and nucleus, provides a new theoretical basis for exploring the neuroprotective mechanism of Sirt1 after brain injury.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Autophagy; Brain injury; Glial activation; Neuroprotection; Sirt1

Mesh:

Substances:

Year:  2019        PMID: 31102754     DOI: 10.1016/j.brainresbull.2019.05.005

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  6 in total

1.  Hypoxic postconditioning-induced neuroprotection increases neuronal autophagy via activation of the SIRT1/FoxO1 signaling pathway in rats with global cerebral ischemia.

Authors:  Junjie Liu; Zehua Gong; Juan Wu; Shaopeng Liu; Xue Wang; Jingyao Wang; Jiwei Xu; Jianmin Li; Yaning Zhao
Journal:  Exp Ther Med       Date:  2021-05-02       Impact factor: 2.447

2.  2, 3, 5, 4'-tetrahydroxystilbene-2-O-beta-D-glucoside protects against neuronal cell death and traumatic brain injury-induced pathophysiology.

Authors:  Yu-Hsin Chen; Yen-Chou Chen; Yu-Tang Chin; Ching-Chiung Wang; Ling-Ling Hwang; Liang-Yo Yang; Dah-Yuu Lu
Journal:  Aging (Albany NY)       Date:  2022-03-21       Impact factor: 5.682

3.  MicroRNA-155-5p promotes neuroinflammation and central sensitization via inhibiting SIRT1 in a nitroglycerin-induced chronic migraine mouse model.

Authors:  Qianwen Wen; Yunfeng Wang; Qi Pan; Ruimin Tian; Dunke Zhang; Guangcheng Qin; Jiying Zhou; Lixue Chen
Journal:  J Neuroinflammation       Date:  2021-12-10       Impact factor: 8.322

Review 4.  Sirtuins functions in central nervous system cells under neurological disorders.

Authors:  Jing Yan; Xiaole Tang; Zhi-Qiang Zhou; Jie Zhang; Yilin Zhao; Shiyong Li; Ailin Luo
Journal:  Front Physiol       Date:  2022-08-30       Impact factor: 4.755

5.  Mir-141-3p Regulates Apoptosis and Mitochondrial Membrane Potential via Targeting Sirtuin1 in a 1-Methyl-4-Phenylpyridinium in vitro Model of Parkinson's Disease.

Authors:  Yumin Zheng; Li Dong; Na Liu; Xiaoguang Luo; Zhiyi He
Journal:  Biomed Res Int       Date:  2020-11-06       Impact factor: 3.411

Review 6.  The Beneficial Roles of SIRT1 in Neuroinflammation-Related Diseases.

Authors:  Fangzhou Jiao; Zuojiong Gong
Journal:  Oxid Med Cell Longev       Date:  2020-09-14       Impact factor: 6.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.